A systematic review and meta-analysis of revascularization outcomes of infrainguinal chronic limb-threatening ischemia
- PMID: 29804736
- DOI: 10.1016/j.jvs.2018.01.066
A systematic review and meta-analysis of revascularization outcomes of infrainguinal chronic limb-threatening ischemia
Abstract
Background: The optimal strategy for revascularization in infrainguinal chronic limb-threatening ischemia (CLTI) remains debatable. Comparative trials are scarce, and daily decisions are often made using anecdotal or low-quality evidence.
Methods: We searched multiple databases through May 7, 2017, for prospective studies with at least 1-year follow-up that evaluated patient-relevant outcomes of infrainguinal revascularization procedures in adults with CLTI. Independent pairs of reviewers selected articles and extracted data. Random-effects meta-analysis was used to pool outcomes across studies.
Results: We included 44 studies that enrolled 8602 patients. Periprocedural outcomes (mortality, amputation, major adverse cardiac events) were similar across treatment modalities. Overall, patients with infrapopliteal disease had higher patency rates of great saphenous vein graft at 1 and 2 years (primary: 87%, 78%; secondary: 94%, 87%, respectively) compared with all other interventions. Prosthetic bypass outcomes were notably inferior to vein bypass in terms of amputation and patency outcomes, especially for below knee targets at 2 years and beyond. Drug-eluting stents demonstrated improved patency over bare-metal stents in infrapopliteal arteries (primary patency: 73% vs 50% at 1 year), and was at least comparable to balloon angioplasty (66% primary patency). Survival, major amputation, and amputation-free survival at 2 years were broadly similar between endovascular interventions and vein bypass, with prosthetic bypass having higher rates of limb loss. Overall, the included studies were at moderate to high risk of bias and the quality of evidence was low.
Conclusions: There are major limitations in the current state of evidence guiding treatment decisions in CLTI, particularly for severe anatomic patterns of disease treated via endovascular means. Periprocedural (30-day) mortality, amputation, and major adverse cardiac events are broadly similar across modalities. Patency rates are highest for saphenous vein bypass, whereas both patency and limb salvage are markedly inferior for prosthetic grafting to below the knee targets. Among endovascular interventions, percutaneous transluminal angioplasty and drug-eluting stents appear comparable for focal infrapopliteal disease, although no studies included long segment tibial lesions. Heterogeneity in patient risk, severity of limb threat, and anatomy treated renders direct comparison of outcomes from the current literature challenging. Future studies should incorporate both limb severity and anatomic staging to best guide clinical decision making in CLTI.
Keywords: Bypass surgery; Critical limb ischemia; Endovascular treatment; Revascularization; Severe limb ischemia.
Copyright © 2018 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.
Similar articles
-
A systematic review and meta-analysis of revascularization outcomes of infrainguinal chronic limb-threatening ischemia.Eur J Vasc Endovasc Surg. 2019 Jul;58(1S):S110-S119. doi: 10.1016/j.ejvs.2019.04.013. Epub 2019 Jun 17. Eur J Vasc Endovasc Surg. 2019. PMID: 31221539
-
A systematic review and meta-analysis of revascularization outcomes of infrainguinal chronic limb-threatening ischemia.J Vasc Surg. 2019 Jun;69(6S):126S-136S. doi: 10.1016/j.jvs.2018.01.071. Epub 2019 May 28. J Vasc Surg. 2019. PMID: 31159976
-
Bypass Surgery With Heparin-Bonded Grafts for Chronic Lower Limb Ischemia.Ann Vasc Surg. 2017 Aug;43:328-346. doi: 10.1016/j.avsg.2017.03.169. Epub 2017 May 4. Ann Vasc Surg. 2017. PMID: 28478165 Review.
-
A meta-analysis to compare Dacron versus polytetrafluroethylene grafts for above-knee femoropopliteal artery bypass.J Vasc Surg. 2014 Aug;60(2):506-15. doi: 10.1016/j.jvs.2014.05.049. Epub 2014 Jun 25. J Vasc Surg. 2014. PMID: 24973288 Review.
-
Comparison of graft patency, limb salvage, and antithrombotic therapy between prosthetic and autogenous below-knee bypass for critical limb ischemia.Ann Vasc Surg. 2013 Nov;27(8):1134-45. doi: 10.1016/j.avsg.2013.01.019. Epub 2013 Sep 5. Ann Vasc Surg. 2013. PMID: 24011814 Free PMC article.
Cited by
-
Vascular resistance index and the immediate hemodynamic success of lower limb distal artery revascularization.J Vasc Bras. 2024 Mar 4;23:e20230119. doi: 10.1590/1677-5449.202301192. eCollection 2024. J Vasc Bras. 2024. PMID: 38487516 Free PMC article.
-
Directional atherectomy for retained valves in a femoropopliteal saphenous vein bypass graft.J Vasc Surg Cases Innov Tech. 2023 Dec 26;10(2):101406. doi: 10.1016/j.jvscit.2023.101406. eCollection 2024 Apr. J Vasc Surg Cases Innov Tech. 2023. PMID: 38379615 Free PMC article.
-
Critical Limb Ischaemia in Octogenarians: Treatment Outcomes Compared With Younger Patients.EJVES Vasc Forum. 2024 Jan 3;61:36-42. doi: 10.1016/j.ejvsvf.2023.12.003. eCollection 2024. EJVES Vasc Forum. 2024. PMID: 38312331 Free PMC article.
-
Angiographic and Clinical Impact of Novel Revascularization for Occluded Femoropopliteal Prosthetic Bypass Graft: A Combination of Surgical Thrombectomy and Drug-Coated Balloon Angioplasty.Case Rep Vasc Med. 2023 Nov 21;2023:6730220. doi: 10.1155/2023/6730220. eCollection 2023. Case Rep Vasc Med. 2023. PMID: 38034082 Free PMC article.
-
Treatment Location Variation for Chronic Limb-Threatening Ischemia in Patients With Kidney Failure.J Surg Res. 2024 Jan;293:300-306. doi: 10.1016/j.jss.2023.09.009. Epub 2023 Oct 6. J Surg Res. 2024. PMID: 37806215
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical